2023 Q1 Form 10-Q Financial Statement

#000156276223000183 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1
Revenue $560.2M
YoY Change 5.58%
Cost Of Revenue $370.7M
YoY Change 10.15%
Gross Profit $189.5M
YoY Change -2.34%
Gross Profit Margin 33.82%
Selling, General & Admin $100.1M
YoY Change 11.27%
% of Gross Profit 52.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.80M
YoY Change 0.98%
% of Gross Profit 7.81%
Operating Expenses $100.1M
YoY Change 11.27%
Operating Profit $72.82M
YoY Change -18.52%
Interest Expense $1.551M
YoY Change 91.48%
% of Operating Profit 2.13%
Other Income/Expense, Net -$103.0K
YoY Change -97.33%
Pretax Income $71.17M
YoY Change -15.98%
Income Tax $17.04M
% Of Pretax Income 23.95%
Net Earnings $54.12M
YoY Change -15.66%
Net Earnings / Revenue 9.66%
Basic Earnings Per Share $3.62
Diluted Earnings Per Share $3.58
COMMON SHARES
Basic Shares Outstanding 14.95M
Diluted Shares Outstanding 15.11M

Balance Sheet

Concept 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.05M
YoY Change 219.68%
Cash & Equivalents $58.05M
Short-Term Investments
Other Short-Term Assets $39.69M
YoY Change 2.47%
Inventory $10.66M
Prepaid Expenses
Receivables $153.8M
Other Receivables $0.00
Total Short-Term Assets $262.2M
YoY Change 41.93%
LONG-TERM ASSETS
Property, Plant & Equipment $204.2M
YoY Change 6.11%
Goodwill $581.3M
YoY Change 0.27%
Intangibles $97.35M
YoY Change -8.48%
Long-Term Investments $97.44M
YoY Change -2.7%
Other Assets $57.51M
YoY Change 599.48%
Total Long-Term Assets $1.169B
YoY Change 4.28%
TOTAL ASSETS
Total Short-Term Assets $262.2M
Total Long-Term Assets $1.169B
Total Assets $1.431B
YoY Change 9.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.28M
YoY Change -37.75%
Accrued Expenses $157.7M
YoY Change -2.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $5.000M
YoY Change
Total Short-Term Liabilities $283.5M
YoY Change 1.36%
LONG-TERM LIABILITIES
Long-Term Debt $16.25M
YoY Change -86.46%
Other Long-Term Liabilities $12.51M
YoY Change 21.05%
Total Long-Term Liabilities $28.76M
YoY Change -77.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $283.5M
Total Long-Term Liabilities $28.76M
Total Liabilities $551.1M
YoY Change -13.76%
SHAREHOLDERS EQUITY
Retained Earnings $2.246B
YoY Change 10.7%
Common Stock $1.223B
YoY Change 11.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.592B
YoY Change 5.1%
Treasury Stock Shares
Shareholders Equity $880.1M
YoY Change
Total Liabilities & Shareholders Equity $1.431B
YoY Change 9.61%

Cashflow Statement

Concept 2023 Q1
OPERATING ACTIVITIES
Net Income $54.12M
YoY Change -15.66%
Depreciation, Depletion And Amortization $14.80M
YoY Change 0.98%
Cash From Operating Activities $60.49M
YoY Change -40.16%
INVESTING ACTIVITIES
Capital Expenditures $17.02M
YoY Change 34.56%
Acquisitions
YoY Change
Other Investing Activities $139.0K
YoY Change -139.6%
Cash From Investing Activities -$17.01M
YoY Change 21.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $76.25M
YoY Change
Cash From Financing Activities -59.55M
YoY Change -41.55%
NET CHANGE
Cash From Operating Activities 60.49M
Cash From Investing Activities -17.01M
Cash From Financing Activities -59.55M
Net Change In Cash -16.07M
YoY Change 9.07%
FREE CASH FLOW
Cash From Operating Activities $60.49M
Capital Expenditures $17.02M
Free Cash Flow $43.47M
YoY Change -50.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139408000
CY2023Q1 us-gaap Inventory Net
InventoryNet
10663000
CY2022Q4 us-gaap Inventory Net
InventoryNet
10272000
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
10633000
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000019584
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-8351
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CHEMED CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0791746
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
18515000
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
29055000
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
255 E. Fifth Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2600
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Cincinnati
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45202
CY2023Q1 dei City Area Code
CityAreaCode
513
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
762-6690
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
30291000
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Capital Stock $1 Par Value
CY2023Q1 dei Trading Symbol
TradingSymbol
CHE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15019778
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58054000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74126000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
153816000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
262221000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
272612000
CY2023Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
97436000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
93196000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
338416000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
335920000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204164000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
199714000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
131219000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135662000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70229000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
67716000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
97348000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
99726000
CY2023Q1 us-gaap Goodwill
Goodwill
581286000
CY2022Q4 us-gaap Goodwill
Goodwill
581295000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
57511000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59807000
CY2023Q1 us-gaap Assets
Assets
1431185000
CY2022Q4 us-gaap Assets
Assets
1442012000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
40279000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
41884000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
11223000
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
63150000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
58515000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50152000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
87350000
CY2023Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
6061000
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
4456000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38291000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38996000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
69304000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61004000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
283460000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
297205000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35418000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38613000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16250000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
92500000
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
97285000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
92330000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106212000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
110513000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12507000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12136000
CY2023Q1 us-gaap Liabilities
Liabilities
551132000
CY2022Q4 us-gaap Liabilities
Liabilities
643297000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36884382
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36795792
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
36884000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
36796000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1186119000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1149899000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2246354000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2197918000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
21927705
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
21920993
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2591588000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2588145000
CY2023Q1 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2284000
CY2022Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2247000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
880053000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
798715000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1431185000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1442012000
CY2023Q1 us-gaap Revenues
Revenues
560157000
CY2022Q1 us-gaap Revenues
Revenues
530549000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
370705000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
336552000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100095000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89954000
CY2023Q1 us-gaap Depreciation
Depreciation
12286000
CY2022Q1 us-gaap Depreciation
Depreciation
12138000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2513000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2518000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1739000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-13000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
487338000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
441175000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
72819000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
89374000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1551000
CY2022Q1 us-gaap Interest Expense
InterestExpense
810000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-103000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3862000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71165000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84702000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17044000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20533000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
64169000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.62
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.28
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14966000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14986000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.22
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15110000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15192000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.38
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
64169000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14799000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14656000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
8482000
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7451000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3195000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4047000
CY2023Q1 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
2024000
CY2022Q1 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
1185000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
95000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14318000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19610000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
391000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
431000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1236000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3099000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-24109000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-30332000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
19118000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
23530000
CY2023Q1 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
632000
CY2022Q1 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-743000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2173000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1562000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5313000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2958000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
122000
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-15000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60492000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101090000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17020000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12649000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
146000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
485000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1650000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
139000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
134000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17013000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13948000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
76250000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25680000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7692000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5685000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5322000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3166000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4893000
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
86500000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27794000
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
21500000
CY2022Q1 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-7051000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-130000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
491000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59551000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-101877000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16072000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14735000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74126000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32895000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58054000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18160000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
798715000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.38
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5685000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
33020000
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-118000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
880053000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
623273000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
64169000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.36
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5322000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11435000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27353000
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
503000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
666705000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1700000
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1400000
CY2023Q1 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
1700000
CY2022Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
1900000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">ESTIMATES</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect amounts reported in the consolidated financial statements and </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">accompanying Notes. Actual results could differ from those estimates. Disclosures of after-tax expenses and adjustments are based on estimates of the effective income tax rates for the applicable segments.</span>
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
319105000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310478000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
306791000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
299189000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
64169000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14966000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.62
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
94000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
50000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
54121000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15110000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
64169000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14986000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.28
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
165000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
41000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
64169000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15192000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.22
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
326000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
609000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
21250000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16250000
CY2023Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3750000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2500000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
21250000
CY2023Q1 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
-321000
CY2022Q1 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
-3934000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
150000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
73000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-103000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3862000
CY2023Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
up to 5 years
CY2023Q1 us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
within 1 year
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000.0
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
131219000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135662000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38291000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38996000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106212000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
110513000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
144503000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
149509000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14906000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14903000
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
23000
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
45000
CY2023Q1 us-gaap Lease Cost
LeaseCost
14883000
CY2022Q1 us-gaap Lease Cost
LeaseCost
14858000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
12668000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
12489000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6845000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20453000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M29D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0264
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
87900000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
34439000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
37667000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30078000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
23143000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12607000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16065000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
153999000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9496000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
144503000
CY2023Q1 che Operating Lease Payments Include To Extended Lease Terms
OperatingLeasePaymentsIncludeToExtendedLeaseTerms
2700000
CY2023Q1 che Lessee Operating Lease Lease Signed But Not Yet Commenced Payments
LesseeOperatingLeaseLeaseSignedButNotYetCommencedPayments
144000000000
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
5873000
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2917000
CY2022Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
0
CY2023Q1 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
0
CY2023Q1 che Oas Receivable
OasReceivable
48422000
CY2022Q4 che Oas Receivable
OasReceivable
50274000
CY2023Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
3640000
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
3636000
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2196000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2368000
CY2023Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1646000
CY2022Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1703000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
1607000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1826000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
57511000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59807000
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000.0
CY2023Q1 che Retention Bonus
RetentionBonus
30551000
CY2022Q4 che Retention Bonus
RetentionBonus
19634000
CY2023Q1 che Medicare Cap Liability
MedicareCapLiability
10365000
CY2022Q4 che Medicare Cap Liability
MedicareCapLiability
14380000
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
28388000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
26990000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
69304000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61004000
CY2023Q1 che Percentage Of Individual Amounts Of Total Current Liabilities
PercentageOfIndividualAmountsOfTotalCurrentLiabilities
0.05
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27353000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
57500
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
475.71
CY2022Q4 us-gaap Goodwill
Goodwill
581295000
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-9000
CY2023Q1 us-gaap Goodwill
Goodwill
581286000

Files In Submission

Name View Source Status
che-20230331_lab.xml Edgar Link unprocessable
0001562762-23-000183-index-headers.html Edgar Link pending
0001562762-23-000183-index.html Edgar Link pending
0001562762-23-000183.txt Edgar Link pending
0001562762-23-000183-xbrl.zip Edgar Link pending
che-20230331.xsd Edgar Link pending
che-20230331x10q.htm Edgar Link pending
che-20230331xex31_1.htm Edgar Link pending
che-20230331xex31_2.htm Edgar Link pending
che-20230331xex31_3.htm Edgar Link pending
che-20230331xex32_1.htm Edgar Link pending
che-20230331xex32_2.htm Edgar Link pending
che-20230331xex32_3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
che-20230331_def.xml Edgar Link unprocessable
che-20230331_pre.xml Edgar Link unprocessable
che-20230331_cal.xml Edgar Link unprocessable
che-20230331x10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable